New drug EI1071 passes first safety check in healthy volunteers
NCT ID NCT04238364
First seen Jun 09, 2026 · Last updated Jun 09, 2026
Summary
This early-stage study tested a new drug, EI1071, in 58 healthy adults to see if it is safe and how the body processes it. Participants received either single or multiple doses of the drug or a placebo. The main goal was to check for side effects and measure drug levels in the blood.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Parexel Early Phase Clinical Unit
Baltimore, Maryland, 21225, United States
Conditions
Explore the condition pages connected to this study.